Taiho Oncology Announces Publication in The New England Jour

/PRNewswire/ -- Taiho Oncology, Inc. today announced the publication of results from the pivotal Phase 2 FOENIX*-CCA2 clinical trial of futibatinib in the...

Related Keywords

Oakville , Ontario , Canada , New Jersey , United States , Switzerland , Canadian , Lipika Goyal , Intrahepatic Cholangiocarcinoma , Judy Kay Moore , Taiho Pharmaceutical Co Ltd , Stanford School Of Medicine , Cancer Center , Drug Administration , Taiho Oncology Inc , Otsuka Holdings Co Ltd , European Society For Medical Oncology , National Comprehensive Cancer Network , Taiho Oncology , New England Journal , Mass General Cancer Center , Associate Professor , Gastrointestinal Cancer , Stanford School , Findings From , Response Evaluation Criteria , Solid Tumors , Visual Analog Scale , Profiling Analysis , Treatment Guidelines , Biliary Tract Cancers , National Comprehensive Cancer , Hepatobiliary Cancers , European Society , Medical Oncology , Clinical Practice Guideline , Pigment Epithelial Detachment , Corneal Keratitis , Soft Tissue Mineralization , Prescribing Information , Oncology Media Contact , Kay Moore , Nc ,